三鑫醫療(300453.SZ):一次性使用醫用口罩獲得美國FDA批准函
格隆匯 1 月 11日丨三鑫醫療(300453.SZ)公佈,近日,公司收到U.S. Food and Drug Administration (美國食品藥品監督管理局,“美國FDA”)批准函,公司的一次性使用醫用口罩(Disposable Medical Face Masks)已通過美國FDA的510 (K)審核。
公司一次性使用醫用口罩獲得美國FDA批准函,表明公司該產品已經具備進入美國市場的准入條件,有利於進一步增強公司產品的綜合競爭力,對公司未來的經營將產生積極影響。但該產品的銷售可能受到國際市場政策環境變化、匯率波動、新冠疫情發展形勢等因素影響,公司目前尚無法預測其對公司未來業績的具體影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.